Harbour BioMed, Harbour Antibodies deal

Harbour BioMed acquired Harbour Antibodies for an undisclosed upfront payment and equity investment. Harbour Antibodies’ H2L2 transgenic mouse platform generates human IgG mAbs with two heavy chain an...